Imbruvica 140mg Capsule (Ibrutinib)

Overview:
Imbruvica 140mg Capsule is a Bruton’s tyrosine kinase (BTK) inhibitor that works by blocking abnormal signaling in B-cells, helping control cancer cell growth and survival. It is used in various hematologic malignancies and can be prescribed as monotherapy or in combination with other treatments.

Uses:

• Treatment of chronic lymphocytic leukemia (CLL).

• Treatment of mantle cell lymphoma (MCL) in patients who have received at least one prior therapy.

• Treatment of Waldenström’s macroglobulinemia.

• Helps control disease progression and improve patient outcomes in blood cancers.

Dosage & Administration:

• Take exactly as prescribed by your hematologist/oncologist.

• Usually taken once daily with or without food.

• Swallow the capsule whole; do not crush, chew, or open.

• Regular blood tests are required to monitor blood counts and organ function.

Precautions:

• Inform your doctor if you have bleeding disorders, infections, heart problems, or low blood counts.

• Possible side effects include diarrhea, fatigue, rash, bruising, infections, and bleeding events.

• Avoid live vaccines during treatment.

• Use effective contraception if pregnancy is possible.

• Store in a cool, dry place, away from light and moisture.

Why Choose Imbruvica 140mg Capsule?

• Clinically proven BTK inhibitor

• Effective targeted therapy for multiple blood cancers

• Improves disease control and patient quality of life

• Convenient oral capsule formulation

Package Includes:

• Each pack contains 30 capsules of 140mg Imbruvica (Ibrutinib)